AI in Healthcare and Digital Health Today—March 16, 2026

https://www.miragenews.com/llnl-study-finds-als-drug-hope-via-ai-veteran-1635264/

Context: This release describes a Lancet Digital Health study of more than 11,000 U.S. veterans with ALS using causal inference and machine learning across 162 medications.

Key point: The team reported 27 drugs associated with significant mortality differences, with repeated positive signals across statins, PDE5 inhibitors, and alpha-adrenergic antagonists.

Implication: Could inform practice and payer discussions, interpretation depends on study design and confounding control.

👨‍⚕️ AMA survey says physician AI use has doubled since 2023 [8] [12 Mar 2026]

https://megadoctornews.com/ama-survey-shows-81-of-doctors-now-using-ai-in-practice/

Context: The AMA said its 2026 Physician Survey on Augmented Intelligence found 81% of doctors now use AI professionally, versus 38% in 2023.

Key point: Documentation and research summarization were common uses, while privacy, liability, patient use, and clinician skill loss remained major concerns.

Implication: May influence workflow design, governance priorities, and vendor evidence requirements.

⚖️ FDA finalizes guidance for weight-loss devices [9] [13 Mar 2026]

https://medicalbuyer.co.in/fda-finalizes-guidance-for-medical-devices-intended-for-weight-loss/

Context: FDA consolidated earlier discussion and draft materials into final guidance for several categories of medical devices intended for weight loss.

Key point: The guidance clarifies non-clinical testing, sham controls where feasible, study design, modified intent-to-treat analysis, PROs, and endpoint timing expectations.

Implication: May affect trial design, evidence generation, and premarket planning for device sponsors.

🏛️ CMS officials push agentic AI at HIMSS26 [10] [12 Mar 2026]

https://www.fiercehealthcare.com/ai-and-machine-learning/himss26-dr-oz-cms-officials-push-agentic-ai-adoption

Context: At HIMSS26, CMS Administrator Mehmet Oz and officials argued that agentic AI could help Medicare beneficiaries navigate plans, doctors, and care decisions.

Key point: The story also notes low trust among older adults, even as CMS ties its Health Tech Ecosystem initiative to patient apps, digital check-in, and conversational AI.

Implication: Signals federal support for patient-facing AI, but beneficiary trust and readiness remain open questions.

🌸 Smart fertility monitors gain visibility in digital health [11] [13 Mar 2026]

https://thefutureofthings.com/27960-the-rise-of-smart-fertility-monitors-in-digital-health-technology/

Context: This article describes the growth of app-connected fertility monitors that track hormones such as estrogen and luteinizing hormone through home testing.

Key point: The piece argues that personalization, convenience, and AI-driven pattern detection are making digital fertility tracking more attractive than manual methods.

Implication: Signals continued consumer demand for home-based reproductive tracking.

🤖 Kody Technolab unveils Medigo Robot [12] [13 Mar 2026]

https://www.digitalhealthnews.com/kody-technolab-unveils-medigo-robot-ai-powered-health-screening-system-for-rapid-preventive-checkups

Context: Kody Technolab said its Medigo Robot can screen more than 65 health indicators and generate a report in about three minutes.

Key point: The system combines screening, multilingual interaction, telemedicine connectivity, and deployment targets that include hospitals, campuses, transit hubs, and public programs.

Implication: May expand screening, initiation, and follow-up at scale.

🧬 Cell paper models a minimal cell in 4D across its full cycle [13] [09 Mar 2026]

https://www.cell.com/cell/fulltext/S0092-8674(26)00174-1 

Context: The Cell paper presents a whole-cell spatial and kinetic model of the genetically minimal bacterium JCVI-syn3A over its roughly 100-minute cell cycle.

Key point: The model integrates gene expression, metabolism, morphology, chromosome dynamics, growth, and division, and the authors say it recovers multiple experimental measurements.

Implication: Could improve hypothesis generation and whole-cell simulation workflows in synthetic and systems biology.

👁️ RETFound Plus adds time-aware retinal disease prediction [14] [14 Mar 2026]

https://www.nature.com/articles/s41746-026-02524-6

Context: RETFound Plus was trained on 1,304,292 fundus photographs from 304,345 participants across multiple visits, with validation across datasets in the UK, US, Singapore, Hong Kong, and Denmark.

Key point: Compared with RETFound, the model improved calibration and 5-year risk prediction, with larger gains reported for systemic outcomes than ocular outcomes.

Implication: Could inform practice and payer discussions, interpretation depends on study design and confounding control.

🧠 Meta-regression tests what works in mental health apps [15] [11 Mar 2026]

https://www.nature.com/articles/s41746-026-02466-z

Context: This npj Digital Medicine meta-analysis coded 34 active elements across 169 trials, 1,137 timepoints, and 41,807 participants.

Key point: Desensitization, stimulus control, and activity scheduling were most strongly linked with depression improvement, while exposure-based elements were strongest for anxiety.

Implication: Could inform practice and payer discussions, interpretation depends on study design and confounding control.

📝 Telehealth summary app is tested in clinical simulation [16] [11 Mar 2026]

https://www.nature.com/articles/s41746-026-02506-8

Context: Researchers used seven clinician-simulated patient dyads in palliative care to test a consultation summary application for video telehealth.

Key point: Clinicians and simulated patients viewed the tool as valuable for recall and self-management, and the paper argues simulation can de-risk deployment before live use.

Implication: Could improve workflow fit and adoption planning before real-world implementation.

🇸🇬 Singapore pilot tests agentic AI for preventive health plans [17] [09 Mar 2026]

https://www.nature.com/articles/s41746-026-02514-8

Context: This pilot in Singapore’s Healthier SG program involved 20 residents and 7 clinicians using a multi-agent assistant for personalized health plans.

Key point: The study reported positive user acceptance, favorable views on personalization and granularity, and no strong concern signal around the recommended plans.

Implication: May expand screening, initiation, and follow-up at scale.

🧪 Lancet Digital Health publishes ALS repurposing study[18] [10 Mar 2026]

https://www.thelancet.com/journals/landig/article/PIIS2589-7500(25)00145-1/fulltext

Context: The paper analyzed Veterans Health Administration records from 11,003 people with ALS and assessed 162 medications with propensity-based methods and survival analysis.

Key point: Statins, PDE5 inhibitors, and alpha-adrenergic antagonists were among the classes associated with reduced hazard of death, while some supportive-care drugs tracked with shorter survival.

Implication: Could inform practice and payer discussions, interpretation depends on study design and confounding control.

🛒 Amazon expands Health AI to its website and app [19] [10 Mar 2026]

https://techcrunch.com/2026/03/10/amazon-launches-its-healthcare-ai-assistant-on-its-website-and-app/

Context: Amazon said Health AI is moving beyond the One Medical app and can answer questions, explain records, manage renewals, and book appointments.

Key point: The company said users do not need Prime or One Medical membership for access, and framed the service as operating in a HIPAA-compliant environment.

Implication: Could streamline initiation and follow-up through a consumer-facing AI entry point into care.

🧫 Cortical Labs and DayOne plan biological-computing data centers [20] [11 Mar 2026]

https://www.tomshardware.com/tech-industry/artificial-intelligence/human-brain-cells-set-to-power-two-new-data-centers-thanks-to-body-in-the-box-cl1-cortical-labs-targets-the-ai-energy-crisis-with-biological-computer-that-reportedly-uses-less-energy-than-a-calculator

Context: Tom’s Hardware, citing Bloomberg, reported plans for CL1-based sites in Melbourne and Singapore using Cortical Labs’ neuron-on-chip biological computer.

Key point: The report says the Melbourne site will use 120 CL1 units, while the Singapore rollout could reach 1,000 units in phases, after a smaller validation phase.

Implication: Signals modality expansion in AI infrastructure, though the technology remains experimental.

🧠 China clears a commercial brain implant, report says [21] [13 Mar 2026]

https://www.scientificamerican.com/article/china-just-approved-its-first-brain-implant-for-commercial-use-a-world-first/

Context: Scientific American reported that Neuracle Medical Technology won commercial approval in China for an invasive brain-computer interface for partial spinal cord injuries.

Key point: The device is described as a coin-sized wireless implant that sits on the brain surface and controls a robotic glove.

Implication: Signals pipeline investment and modality expansion in brain-computer interfaces.

🧾 SynthCraft uses LLMs to guide synthetic-data workflows [22] [09 Mar 2026]

https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001290

Context: SynthCraft combines a reasoning engine, LLM agents, and SynthCity tools to help users generate and evaluate synthetic healthcare data through natural language.

Key point: In NHANES and TCGA demonstrations, no single generator was best across privacy, fidelity, and downstream utility, and the system logged steps for transparency.

Implication: Could improve reproducibility and access to advanced synthetic-data workflows in biomedical research.

🧠 Korean groups bring Alzheimer’s updates to AD/PD 2026 [23] [13 Mar 2026]

https://www.koreabiomed.com/news/articleView.html?idxno=30916

Context: The conference preview says Korean companies spanning therapeutics, imaging AI, and digital therapeutics will present at AD/PD 2026 in Copenhagen.

Key point: AriBio will share Phase 3 Polaris-AD updates for AR1001, while Neurophet is presenting Alzheimer’s imaging-analysis tools and related research abstracts.

Implication: Signals pipeline investment and modality expansion in Alzheimer’s R&D.

🇮🇪 Ireland launches national AI for Care strategy [24] [13 Mar 2026]

https://www.euractiv.com/news/ireland-unveils-new-ai-health-strategy-clinician-oversight-maintained/

Context: Ireland’s first national AI plan for health and social care lays out a five-year roadmap across clinical care, operations, research and innovation, and public health.

Key point: The government said clinicians will remain responsible, patient-facing clinical AI will need certification, and implementation will align with the EU AI Act.

Implication: May expand screening, initiation, and follow-up at scale.